The Role of Nutrients in the Development, Progression, and Treatment of Nonalcoholic Fatty Liver Disease

被引:93
|
作者
Mouzaki, Marialena [1 ]
Allard, Johane P. [2 ]
机构
[1] Hosp Sick Children, Dept Gastroenterol Hepatol & Nutr, Toronto, ON M5G 1X8, Canada
[2] Univ Toronto, Dept Med, Univ Hlth Network, Toronto, ON, Canada
关键词
NAFLD; fatty liver; nutrition; diet; obesity; INDUCED INSULIN-RESISTANCE; INDUCED HEPATIC STEATOSIS; LIFE-STYLE INTERVENTION; PHYSICAL-ACTIVITY; VITAMIN-E; GLYCEMIC INDEX; IRON OVERLOAD; WEIGHT-LOSS; CARDIORESPIRATORY FITNESS; DIETARY REQUIREMENTS;
D O I
10.1097/MCG.0b013e31824cf51e
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Nonalcoholic fatty liver disease (NAFLD) is the most common cause of liver disease in adults and children and is currently the third most common indication for liver transplantation in North America. Its pathogenesis is thought to be secondary to multiple "hits" derived from the dietary components, adipose tissue, immune system, and intestinal microbiota. Lack of physical activity may contribute as well. Nutrients may exert their effect directly or through alteration of the intestinal microbiota. Research focusing on specific dietary components predisposing to NAFLD has shown conflicting results. Total energy intake, and macronutrients, has been linked to the development of NAFLD. Fructose not only contributes to hepatic steatosis but may trigger inflammatory signals as well. Polyunsaturated fatty acids are thought to exert anti-inflammatory effects. The role of vitamins as well as minerals in this field is actively being investigated. In this review, we discuss the evidence-linking macronutrients (such as carbohydrates and fat in general and fructose, fiber, short chain fatty acids, polyunsaturated fatty, and choline specifically) and micronutrients (such as vitamin E and C and minerals) with the development and treatment of NAFLD. We also discuss the literature on physical activity and NAFLD.
引用
收藏
页码:457 / 467
页数:11
相关论文
共 50 条
  • [31] Role at TLR4 in development of nonalcoholic fatty liver disease
    Matsumoto, H
    Fujii, K
    Nishitani, Y
    Okazaki, S
    Yajima, H
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2005, 29 (05) : 124A - 124A
  • [32] Role of MicroRNAs in the Development of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
    Zhang, Cheng
    Wang, Ping
    Li, Yongqiang
    Huang, Changxin
    Ni, Wei
    Chen, Yidan
    Shi, Junping
    Chen, Gongying
    Hu, Xiangrong
    Ye, Meng
    Duan, Shiwei
    Wang, Kaifeng
    ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY, 2019, 302 (02): : 193 - 200
  • [33] New Insights into the Role of Iron in the Development of Nonalcoholic Fatty Liver Disease
    Sharp, Paul A.
    HEPATOLOGY, 2010, 52 (02) : 408 - 410
  • [34] Role of liver biopsy in nonalcoholic fatty liver disease
    ILKe Nalbantoglu
    Elizabeth M Brunt
    World Journal of Gastroenterology, 2014, (27) : 9026 - 9037
  • [35] Role of intestinal flora in the development of nonalcoholic fatty liver disease in children
    Zhang, Jing
    Shi, Mengxuan
    Zhao, Chunna
    Liang, Guangcai
    Li, Chuan
    Ge, Xiaomeng
    Pei, Caixia
    Kong, Yawei
    Li, Dongdan
    Yang, Wenli
    Cao, Bingyan
    Fu, Libing
    Yan, Yinkun
    Wu, Jie
    Zhou, Jin
    Fang, Yongli
    Meng, Xi
    Li, Yong
    Wang, Liming
    MICROBIOLOGY SPECTRUM, 2024, 12 (02):
  • [36] Role of liver biopsy in nonalcoholic fatty liver disease
    Nalbantoglu, ILKe
    Brunt, Elizabeth M.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (27) : 9026 - 9037
  • [37] GPCRs get fatty: the role of G protein-coupled receptor signaling in the development and progression of nonalcoholic fatty liver disease
    Kurtz, Ryan
    Anderman, Meghan F.
    Shepard, Blythe D.
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2020, 320 (03): : G304 - G318
  • [38] Role of Agents for the Treatment of Diabetes in the Management of Nonalcoholic Fatty Liver Disease
    Budd, Jeffrey
    Cusi, Kenneth
    CURRENT DIABETES REPORTS, 2020, 20 (11)
  • [39] Role of Bile Acids in Dysbiosis and Treatment of Nonalcoholic Fatty Liver Disease
    Wang, Caihua
    Zhu, Chunpeng
    Shao, Liming
    Ye, Jun
    Shen, Yimin
    Ren, Yuezhong
    MEDIATORS OF INFLAMMATION, 2019, 2019
  • [40] Role of Agents for the Treatment of Diabetes in the Management of Nonalcoholic Fatty Liver Disease
    Jeffrey Budd
    Kenneth Cusi
    Current Diabetes Reports, 2020, 20